The Lancet HIV in conversation with

Ricardo Luque and Miguel Barriga on HIV prevalence and care continuum among migrants from Venezuela in Colombia (en Español)

Adrian Gonzalez (Deputy Editor) entrevista a Ricardo Luque (Oficina de Salud y Derechos Sexuales y Reproductivos del Ministerio de Salud y Protección Social, Colombia) y Miguel Barriga (Organización de base comunitaria "Red Somos", Colombia) sobre la situación sanitaria de los migrantes Venezolanos con VIH en Colombia.Read the full article:https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(23)00085-1/fulltext?dgcid=buzzsprout_icw_podcast_generic_lanhivContinue this conversation on social!Follow us today at...https://thelancet.bsky.social/https://instagram.com/thelancetgrouphttps://facebook.com/thelancetmedicaljournalhttps://linkedIn.com/company/the-lancethttps://youtube.com/thelancettv

Denton Callander on the effects of treatment as prevention

Peter Hayward is joined by Denton Callander (Sexual Health Programme, Kirby Institute, New South Wales, Australia) to discuss the effects of treatment as prevention on HIV epidemiology among men who have sex with men in Australia.Read the full article:https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(23)00050-4/fulltext?dgcid=buzzsprout_icw_podcast_generic_lanhivContinue this conversation on social!Follow us today at...https://thelancet.bsky.social/https://instagram.com/thelancetgrouphttps://facebook.com/thelancetmedicaljournalhttps://linkedIn.com/company/the-lancethttps://youtube.com/thelancettv

Andrea Wirtz and Sari Reisner on HIV incidence and mortality among transgender women

Editor-in-Chief Peter Hayward is joined by Andrea Wirtz (Johns Hopkins School of Public Health) and Sari Reisner (Harvard School of Public Health) to discuss their research in HIV incidence and mortality among transgender women in the eastern and southern USA.Read the full article:https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(23)00008-5/fulltext?dgcid=buzzsprout_icw_podcast_lanhiv_lancetContinue this conversation on social!Follow us today at...https://thelancet.bsky.social/https://instagram.com/thelancetgrouphttps://facebook.com/thelancetmedicaljournalhttps://linkedIn.com/company/the-lancethttps://youtube.com/thelancettv

Yasmin Mohamed on early infant diagnosis of HIV

Peter Hayward speaks to Yasmin Mohamed (Burnet Institute, Melbourne, Australia) about a trial of point-of-care early infant diagnosis of HIV in Myanmar and Papua New Guinea.Read the full article:The effect of the Xpert HIV-1 Qual test on early infant diagnosis of HIV in Myanmar and Papua New GuineaContinue this conversation on social!Follow us today at...https://thelancet.bsky.social/https://instagram.com/thelancetgrouphttps://facebook.com/thelancetmedicaljournalhttps://linkedIn.com/company/the-lancethttps://youtube.com/thelancettv

Salome Kuchukhidze and Francisco Mbofana on intimate partner violence and women with HIV

Peter Hayward is joined by Salome Kuchukhidze (McGill University Department of Epidemiology, Biostatistics, and Occupational Health, Montreal, Canada) and Francisco Mbofana (National AIDS Council, Maputo, Mozambique) to talk about the effects of intimate partner violence on women's risk of HIV acquisition and engagement in the HIV treatment and care cascade.Read the full article:The effects of intimate partner violence on women's risk of HIV acquisition and engagement in the HIV treatment and care cascadeContinue this conversation on social!Follow us today at...https://thelancet.bsky.social/https://instagram.com/thelancetgrouphttps://facebook.com/thelancetmedicaljournalhttps://linkedIn.com/company/the-lancethttps://youtube.com/thelancettv

Lise Jamieson and Gesine Mayer-Rath on cabotegravir for PrEP in South Africa

Deputy Editor Philippa Harris talks to Lise Jamieson (Health Economics and Epidemiology Research Office, University of Witswatersrand, South Africa) and Gesine Mayer-Rath (Health Economics and Epidemiology Research Office and the University of Boston, USA) about cost-effectiveness of long-acting cabotegravir for PrEP in South Africa. Read the full article:Relative cost-effectiveness of long-acting injectable cabotegravir versus oral pre-exposure prophylaxis in South Africa based on the HPTN 083 and HPTN 084 trialsContinue this conversation on social!Follow us today at...https://thelancet.bsky.social/https://instagram.com/thelancetgrouphttps://facebook.com/thelancetmedicaljournalhttps://linkedIn.com/company/the-lancethttps://youtube.com/thelancettv

Helen Ayles and Musonda Simwinge on the PopART trial

Helen Ayles (London School of Hygiene and Tropical Medicine) and Musonda Simwinga (Zambart) join Peter Hayward to discuss PopART trial (HPTN 071) papers published in the November issue of The Lancet HIV.Read the PopART trial papers:Viral suppression and self-reported ART adherence after 3 years of universal testing and treatment in the HPTN 071 (PopART) communityImpact of universal testing and treatment on sexual risk behaviour and herpes simplex virus type 2Projected outcomes of universal testing and treatment in a generalised HIV epidemic in Zambia and South AfricaContinue this conversation on social!Follow us today at...https://thelancet.bsky.social/https://instagram.com/thelancetgrouphttps://facebook.com/thelancetmedicaljournalhttps://linkedIn.com/company/the-lancethttps://youtube.com/thelancettv

Carol Strong and Stephane Ku on HIV and chemsex

Carol Strong (National Cheng Kung University, Taiwan) and Stephane Ku (Taipei City Hospital, Taiwan) join Deputy Editor Philippa Harris to talk about HIV and chemsex.Read the full Review:HIV, chemsex, and the need for harm-reduction interventions to support gay, bisexual, and other men who have sex with menContinue this conversation on social!Follow us today at...https://thelancet.bsky.social/https://instagram.com/thelancetgrouphttps://facebook.com/thelancetmedicaljournalhttps://linkedIn.com/company/the-lancethttps://youtube.com/thelancettv

Elijah Kakande and Gabriel Chamie on TB interventions for people with HIV

Peter Hayward talks to Elijah Kakande (Infectious Diseases Research Collaboration, Uganda) and Gabriel Chamie (University of California at San Francisco, USA) about an intervention to increase tuberculosis prevention uptake among people with HIV in Uganda.Read the full article:A mid-level health manager intervention to promote uptake of isoniazid preventive therapy among people with HIV in UgandaContinue this conversation on social!Follow us today at...https://thelancet.bsky.social/https://instagram.com/thelancetgrouphttps://facebook.com/thelancetmedicaljournalhttps://linkedIn.com/company/the-lancethttps://youtube.com/thelancettv

Amir Mohareb on PrEP and hepatitis B

Philippa Harris talks to Amir Mohareb (Massachusetts General Hospital, USA) about PrEP for people living with chronic hepatitis B. Read the full article:Risks and benefits of oral HIV pre-exposure prophylaxis for people with chronic hepatitis BContinue this conversation on social!Follow us today at...https://thelancet.bsky.social/https://instagram.com/thelancetgrouphttps://facebook.com/thelancetmedicaljournalhttps://linkedIn.com/company/the-lancethttps://youtube.com/thelancettv